Harpoon Therapeutics Presents Data on its TriTAC-XR Platform at the 36th Annual Meeting of the Society for Immunotherapy of Cancer - Arix Bioscience

Close Navigation

About Strategy Team Portfolio Insights Media Contact

Overlay

Harpoon Therapeutics Presents Data on its TriTAC-XR Platform at the 36th Annual Meeting of the Society for Immunotherapy of Cancer

12th November 2021

Portfolio

This post references, or is about Harpoon. Find out more by clicking below

San Francisco, CA, US

Useful Tools

Download, print or share this article

Print

Print Article Email

Email

Print

Share Article